A father dreamed of a home for his family. Medical debt nearly pushed them onto the streets.

Kayce Atencio used to be haunted by a thought while working at a homeless shelter in downtown Denver. “It could have been me,” said Atencio, 30, who lives in a small apartment with his son and daughter not far from the shelter.

India’s Glenmark Pharmaceuticals divests 75% stake in its API manufacturing subsidiary

Generics producer Glenmark Pharmaceuticals is divesting almost completely from its active pharmaceutical ingredient (API)-manufacturing subsidiary, selling 75% of its shares to Nirma Limited for $7.41

September 23, 2023

Scientists discover how a gut insulin antagonist controls fat loss in C. elegans by modulating brain signals

Researchers have identified an endogenous insulin antagonist, INS-7, in Caenorhabditis elegans that modulates fat loss by inhibiting a gut-to-brain signaling pathway involving the neuropeptide FLP-7.

August 27, 2024

‘Significant Milestone’ for Radionuclide Therapy in Refractory Meningioma

Use of an approved radionuclide therapy for difficult-to-treat meningioma was associated with substantially improved progression-free survival (PFS) compared with a historical benchmark, according to results

October 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.